Respiratory syncytial virus infection prolongs methacholine-induced airway hyperresponsiveness in ovalbumin-sensitized mice
- 29 January 1999
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 57 (2) , 186-192
- https://doi.org/10.1002/(sici)1096-9071(199902)57:2<186::aid-jmv17>3.0.co;2-q
Abstract
Severe respiratory syncytial virus (RSV)-induced disease is associated with childhood asthma and atopy. We combined models of allergen sensitization and RSV infection to begin exploring the immunologic interactions between allergic and virus-induced airway inflammation and its impact on airway hypersensitivity. Airway resistance was measured after methacholine challenge in tracheally intubated mice by whole body plethysmography. Lung inflammation was assessed by bronchoalveolar lavage (BAL) and histopathology. RSV infection alone did not cause significant airway hyperresponsiveness (AHR) to methacholine. Ovalbumin (OVA)-induced AHR lasted only a few days past the discontinuance of OVA aerosol in mice that were ovalbumin sensitized and mock infected. In contrast, OVA-sensitized mice infected with RSV during the OVA aerosol treatments (OVA/RSV) had AHR for more than 2 weeks after infection. However, 2 weeks after either RSV or mock infection, OVA/RSV mice had significantly more lymphocytes found during BAL than OVA mice, whereas the OVA and OVA/RSV groups had the same number of eosinophils. Histopathologic analysis confirmed an increased inflammation in the lungs of OVA/RSV mice compared with OVA mice. In addition, OVA/RSV mice had a more widespread distribution of mucus in their airways with increased amounts of intraluminal mucus pools compared with the other groups. Thus, prolonged AHR in RSV-infected mice during ovalbumin-sensitization correlates with increased numbers of lymphocytes in BAL fluid, increased lung inflammation, and mucus deposition in the airways, but not with airway eosinophilia. A further understanding of the immunologic consequences of combined allergic and virus-induced airway inflammation will impact the management of diseases associated with airway hyperreactivity. J. Med. Virol. 57:186–192, 1999.Keywords
This publication has 25 references indexed in Scilit:
- Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma.Journal of Clinical Investigation, 1997
- Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.Journal of Clinical Investigation, 1997
- Decreased nasal goblet cells in patients reporting topical corticosteroid useJournal of Allergy and Clinical Immunology, 1997
- Inhibition of T cell costimulation abrogates airway hyperresponsiveness in a murine model.Journal of Clinical Investigation, 1996
- Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.The Journal of Experimental Medicine, 1996
- Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.The Journal of Experimental Medicine, 1995
- Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.Journal of Clinical Investigation, 1991
- Primary respiratory syncytial virus infection in miceJournal of Medical Virology, 1988
- Modulation of Systemic and Mucosal Immune Responses to Inhaled Ragweed Antigen in Experimentally Induced Infection with Respiratory Syncytial Virus Implication in Virally Induced AllergyInternational Archives of Allergy and Immunology, 1988
- The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic childrenThe Journal of Pediatrics, 1973